ACOG
Alpha Cognition Inc
NASDAQ: ACOG · HEALTHCARE · BIOTECHNOLOGY
$5.87
-5.32% today
Updated 2026-04-29
Market cap
$127.81M
P/E ratio
—
P/S ratio
12.51x
EPS (TTM)
$-1.18
Dividend yield
—
52W range
$5 – $12
Volume
0.1M
Alpha Cognition Inc (ACOG) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $10.22M |
| Revenue growth (YoY) | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | $81220.00 | $1.92M |
| Gross profit | — | — | — | — | $-81220.00 | $8.30M |
| Gross margin | — | — | — | — | — | 81.3% |
| R&D | $4.67M | $7.97M | $8.82M | $5.00M | $3.92M | $1.87M |
| SG&A | $950442.00 | $3.28M | $4.02M | $4.67M | $7.22M | $27.23M |
| Operating income | $-5.71M | $-11.57M | $-13.47M | $-9.62M | $-11.86M | $-22.66M |
| Operating margin | — | — | — | — | — | -221.7% |
| EBITDA | $-4.93M | $-18.93M | $-11.85M | $-13.62M | $-14.37M | $-22.66M |
| EBITDA margin | — | — | — | — | — | -221.7% |
| EBIT | $-5.01M | $-19.02M | $-11.94M | $-13.70M | $-14.45M | $-22.72M |
| Interest expense | $770371.00 | $528160.00 | $172880.00 | $67712.00 | $185777.00 | — |
| Income tax | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-5.78M | $-19.55M | $-12.11M | $-13.77M | $-14.64M | $-20.67M |
| Net income growth (YoY) | — | -237.9% | +38.0% | -13.7% | -6.3% | -41.2% |
| Profit margin | — | — | — | — | — | -202.2% |